How to Buy Caris Life Sciences Stock
Caris Life Sciences Inc
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally.
Caris Life Sciences stock last closed at $20.00, up 21.58% from the previous day, and has decreased 30.92% in one year. It has underperformed other stocks in the Biotechnology industry by 0.22 percentage points. Caris Life Sciences stock is currently +40.94% from its 52-week low of $14.19, and -52.94% from its 52-week high of $42.50.
At the moment, there are 282.6M CAI shares outstanding. The market cap of CAI is $5.65B. In the last 24 hours, 11.27M CAI shares were traded.
How to Buy Caris Life Sciences Stock
Not sure how to invest in Caris Life Sciences stock? Here's how.
- Decide where to buy Caris Life Sciences stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Caris Life Sciences stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Select your method of payment and add your details.
- Evaluate Caris Life Sciences stock: The Caris Life Sciences ticker symbol is CAI. Is Caris Life Sciences stock a good investment? Should you buy shares of CAI? How do CAI's underlying business fundamentals look? Do top analysts think Caris Life Sciences is a good buy? Why has CAI's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if CAI is a good stock to buy).
- Make your CAI trade: Decide if you will purchase CAI shares at the current market price or use a limit order to purchase CAI stock at a particular price.
- Keep tabs on your CAI position: Create a watchlist to important updates regarding your investment in Caris Life Sciences shares.
Step 1: Decide where to buy Caris Life Sciences stock
You need a brokerage account to access the NASDAQ market and buy CAI stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you are able to buy CAI today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open your new brokerage account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've opened your account on the best stock broker app, your next step is to transfer the money for your investment:
Watch the tutorial below for more details transferring funds into your new investment account.
Step 4: Evaluate Caris Life Sciences stock
Once you have figured out the best place to buy Caris Life Sciences stock, it's critical to research their stock before you buy, so you actually wrap your head around the risk as well as the upside.
Caris Life Sciences Metrics
Fundamentals of CAI
WallStreetZen was created to help everyday investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on CAI's stock page.
Is CAI stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge CAI's fair value.
Using relative valuations ratios:
- CAI could be undervalued based on its P/E ratio of 11.76x, relative to Biotechnology industry P/E ratio of 14.46x
- CAI may be overvalued based on its P/B ratio of 9.55x, relative to Biotechnology industry P/B ratio of 5.72x
You can access more valuation research on CAI's stock here.
A look at CAI Cashflows and Balance Sheet
Positive Financial Indicators:
- CAI profit margin has gone up from -149.6% to 10.6% in the past year.
- There are more short-term assets than short-term liabilities on the CAI balance sheet.
- CAI's operating cash flow of $168.56M allows it to safely service it's debt of $393.15M.
- There are more short-term assets than long-term liabilities on the CAI balance sheet.
Negative Financial Indicators:
- CAI earnings of $151.92M is not sufficient to cover its interest payments.
- CAI has a relatively high debt to equity ratio of 1.08.
Do analysts think it's a good time to buy CAI stock
Out of 8 Equities analysts who monitor CAI, the consensus analyst rating on Caris Life Sciences is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent CAI Analyst Forecasts
David Westenberg, a top 1% analyst from Piper Sandler initiates coverage on CAI with a hold rating and announces their CAI price target of $21.00, on Apr 10, 2026.
Kyle Mikson, a top 22% analyst from Canaccord Genuity maintains CAI with a hold rating and lowers their CAI price target from $30.00 to $22.00, on Mar 13, 2026.
Catherine Schulte, a top 2% analyst from Baird maintains CAI with a buy rating and raises their CAI price target from $26.00 to $28.00, on Feb 27, 2026.
You can dig deeper into what analysts are projecting on the Caris Life Sciences stock forecast page.
CAI Trading Indicators
Is CAI Making Money?
Last year, CAI revenue was $989.61M. Over the last one years, CAI's revenue has gone up by 85.37% per year. This was faster than the Biotechnology industry average of 32.42%.
Learn more about CAI's earnings and revenue performance here.
Who is buying/selling CAI?
Over the last year, executives and large shareholders at CAI have sold more shares than they have bought.
Jonathan Kenneth Charles Knowles, Director of CAI, was the latest CAI insider to buy. They bought $24,992.00 worth of CAI shares on May 29, 2026.
Research more about who owns CAI shares here.
Can I get consistent income from CAI stock?
No, Caris Life Sciences doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your CAI trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount limit, place a limit order.
Press the Open button and eToro will place the order.
If you want more assistance buying stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your CAI position
Now that you own some CAI shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track the latest developments regarding your CAI stock.
CAI Feed
How to Buy Stock in Caris Life Sciences
To summarize, here are the 6 steps to buy stock in Caris Life Sciences:
- Decide where to buy Caris Life Sciences stock
- Open your brokerage account
- Deposit money your investment account
- Evaluate Caris Life Sciences stock
- Make your CAI trade
- Keep tabs on your CAI position
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Caris Life Sciences, create a watchlist on WallStreetZen today.
Other "How To" Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.